Yardley Dermatology Associates PC — research payments reported

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$1,595	4
2024	Research	$1,994	5
2023	Research	$2,393	6
2022	Research	$2,086	7
2021	Research	$4,082	11
2020	Research	$3,288	9
2019	Research	$77,918	14

Breakdown

Who paid Research payments · program years 2019–2025

Eli Lilly and Company $55,722 4 payments
LEO Pharma AS $20,508 5 payments
Regeneron Pharmaceuticals, Inc. $17,125 47 payments

Studies the money was for Research payments · program years 2019–2025

A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-To-Severe Plaque Psoriasis $55,722 4 payments
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - Ecztra 2 Eczema Tralokinumab Trial No. 2 Ecztra 2 $20,508 5 payments
A Prospective Observational Study of Adult Patients Receiving Dupixent for Atopic Dermatitis $9,058 25 payments
A Prospective Observational Study of Patients Receiving Dupixent for Atopic Dermatitis $8,067 22 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.